Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methocarbamol measurement (procedure) |
Component |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol poisoning |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol adverse reaction |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Allergy to methocarbamol |
Causative agent (attribute) |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Methocarbamol overdose |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Accidental methocarbamol overdose |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Intentional methocarbamol overdose |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
surdose de méthocarbamol d'intention indéterminée |
Causative agent (attribute) |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Methocarbamol 100mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Methocarbamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Poisoning by methocarbamol |
Causative agent (attribute) |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Product containing methocarbamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and methocarbamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |
Allergy to methocarbamol |
Causative agent (attribute) |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 750 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 750 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin- and methocarbamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |
Product containing methocarbamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin and methocarbamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |
Methocarbamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Methocarbamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
1 |
Aspirin and methocarbamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methocarbamol (substance) |
Inferred relationship |
Some |
2 |